Shopping Cart
- Remove All
Your shopping cart is currently empty
CPL207280
😃Good
Catalog No. T86087Cas No. 2361497-72-3
CPL207280, an orally active GPR40/FFA1 agonist with antidiabetic effects, enhances glucose-stimulated insulin secretion and improves glucose tolerance in MIN6 pancreatic β-cells, healthy Wistar Han rats, and diabetic rat models, making it a valuable compound for type 2 diabetes research [1] [2].
CPL207280
😃Good
Catalog No. T86087Cas No. 2361497-72-3
CPL207280, an orally active GPR40/FFA1 agonist with antidiabetic effects, enhances glucose-stimulated insulin secretion and improves glucose tolerance in MIN6 pancreatic β-cells, healthy Wistar Han rats, and diabetic rat models, making it a valuable compound for type 2 diabetes research [1] [2].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | CPL207280, an orally active GPR40/FFA1 agonist with antidiabetic effects, enhances glucose-stimulated insulin secretion and improves glucose tolerance in MIN6 pancreatic β-cells, healthy Wistar Han rats, and diabetic rat models, making it a valuable compound for type 2 diabetes research [1] [2]. |
| In vivo | CPL207280, administered as a single oral dose of 10 mg/kg, exhibits hypoglycemic effects in Wistar Han rats. Its pharmacokinetic parameters at a 3 mg/kg oral dose include a Cmax of 1699 ng/mL, Tmax of 1 hour, and T1/2 of 1.41 hours [1]. |
| Molecular Weight | 286.37 |
| Formula | C18H22O3 |
| Cas No. | 2361497-72-3 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy CPL207280 | purchase CPL207280 | CPL207280 cost | order CPL207280 | CPL207280 chemical structure | CPL207280 in vivo | CPL207280 formula | CPL207280 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.